Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> PFIZER Latest News

6 HOURS AGO - Yahoo! News

A Must Read - Share

Pfizer's need for deal looms larger with earnings report

By Ransdell Pierson NEW YORK (Reuters) - Pfizer Inc's vulnerability to cheaper generics and its weak roster of experimental medicines will be on display Tuesday when the company reports quarterly earnings, reviving interest in its pursuit of AstraZeneca Plc or other deals to fortify its pipeline. While many industry watchers expect Pfizer to re-engage with Britain's AstraZeneca in coming months, ...

Tags: Pfizer's need for deal looms larger with earnings report,  Pfizer Latest News

JUL 14, 2014 - Yahoo! News

A Must Read - Share

Targacept ends Alzheimer's drug trial after mid-stage failure

(Reuters) - Targacept Inc said it was ending a mid-stage trial on its Alzheimer's drug as it did not show superiority over standard medication, sending its shares down as much as 19.8 percent. The drug, TC-1734, which was being tested against Pfizer Inc's donepezil, had earlier failed another mid-stage trial conducted by partner AstraZeneca Plc. "Based on (today's) results, we ...

Tags: Targacept ends Alzheimer's drug trial after mid-stage failure,  Pfizer Latest News

JUL 14, 2014 - Yahoo! News

A Must Read - Share

Targacept stops Alzheimer's drug trial after it fails mid-stage

(Reuters) - Targacept Inc said its experimental Alzheimer's drug did not show superiority over standard medication in a mid-stage study and that it would no longer invest in the development of the treatment. The company's shares were down about 16.44 percent. The drug, TC-1734, was being tested against Pfizer Inc's donepezil. (Reporting By Amrutha Penumudi; Editing by Don Sebastian)

Tags: Targacept stops Alzheimer's drug trial after it fails mid-stage,  Pfizer Latest News

JUL 14, 2014 - Yahoo! News

A Must Read - Share

Shire ready to bow to AbbVie's increased $53 billion offer

By Kate Holton LONDON (Reuters) - London-listed drugmaker Shire Plc succumbed to an increased 31 billion pounds ($53 billion) takeover offer from Abbvie Inc on Monday, signaling the conclusion to a long-running courtship largely motivated by tax. Shire said it was ready to recommend the deal, the latest in a list of mergers proposed by U.S. firms seeking to cut ...

Tags: Shire ready to bow to AbbVie's increased $53 billion offer,  Pfizer Latest News

JUL 08, 2014 - Yahoo! News

A Must Read - Share

Pfizer wins dismissal of U.S. investor class action ahead of trial

By Nate Raymond NEW YORK (Reuters) - Pfizer Inc won the dismissal Tuesday of a long-running shareholder class action accusing the company of misleading investors about the safety of its Celebrex and Bextra pain-relieving drugs. The ruling by U.S. District Judge Laura Taylor Swain in New York came ahead of a Sept. 9 trial in the case, which investors launched ...

Tags: Pfizer wins dismissal of U.S. investor class action ahead of trial,  Pfizer Latest News